Clorox Reports Q1 Fiscal Year 2024 Results, Updates Outlook
- None.
- None.
First-Quarter Fiscal Year 2024 Summary
Following is a summary of key results for the first quarter, which was marked by the impact of the previously announced cyberattack. All comparisons are with the first quarter of fiscal year 2023 unless otherwise stated.
- Net sales decreased
20% to compared to a$1.4 billion 4% net sales decrease in the year-ago quarter. The decrease was driven largely by lower volume resulting from the cyberattack, partially offset by favorable price mix. Organic sales1 were down18% . - Gross margin increased 240 basis points to
38.4% from36.0% in the year-ago quarter, due to the benefits of pricing and cost-savings initiatives, partially offset by the impact of lower volume. - Diluted net earnings per share (diluted EPS) decreased
75% to17 cents from68 cents in the year-ago quarter. This decrease includes current-period investments in the company's long-term strategic digital capabilities and productivity enhancements (17 cents ) and incremental expenses resulting from the cyberattack (15 cents ). - Adjusted EPS1 decreased
47% to49 cents from93 cents in the year-ago quarter, due to lower volume partially offset by the benefits of pricing and ongoing cost-savings initiatives. - Year-to-date net cash provided by operations was
compared to$20 million in the year-ago period, representing an$178 million 89% decrease.
"After entering the fiscal year with solid momentum, the August cyberattack caused wide-scale disruptions that are impacting our short-term financial performance," said CEO Linda Rendle. "Looking forward, our near-term priorities are clear: We are laser focused on rebuilding customer inventories, preserving merchandising activities, and ultimately rebuilding distribution and market share. We are confident that our portfolio of leading brands in essential categories and our IGNITE strategy will enable us to deliver consistent, profitable growth over time."
This press release includes certain non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more details.
Strategic and Operational Highlights
The following are recent highlights of business and environmental, social and governance achievements:
- Delivered another quarter of strong cost savings as part of the company's effort to rebuild margin.
- Improved volume consumption trends enterprisewide prior to the cyberattack while lapping major pricing actions in the year-ago period.
- Successfully executed pricing to offset higher costs, generating organic sales growth in the International segment.
- Named Safer Choice Partner of the Year by the
U.S. Environmental Protection Agency, the sixth time the company has been recognized with this award acknowledging efforts to manufacture products with ingredients designated as safer for families, pets, workplaces, communities and the environment.
Key Segment Results
The following is a summary of key first-quarter results by reportable segment. It reflects the impact of the previously announced cyberattack, which drove lower sales in all segments and lower segment adjusted earnings before interest and income taxes, or adjusted EBIT2, in three of four segments. All comparisons are with the first quarter of fiscal year 2023, unless otherwise stated. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2023.
Health and Wellness (Cleaning; Professional Products)
- Net sales were down
23% , with 29 points of lower volume partially offset by 6 points from favorable price mix. Results reflect decreases in both businesses. - Segment adjusted EBIT was down
22% , driven primarily by the impact of lower volume partially offset by the benefit of pricing.
Household (Bags and Wraps; Cat Litter; Grilling)
- Net sales were down
23% , with 30 points of lower volume more than offsetting 7 points from favorable price mix. Results reflect decreases in all three businesses. - Segment adjusted EBIT was down
118% , primarily due to lower volume. The decrease was partially offset by the benefits of cost-savings initiatives and pricing.
Lifestyle (Food; Natural Personal Care; Water Filtration)
- Net sales were down
28% , driven by 37 points of lower volume partially offset by 9 points of favorable price mix. Results reflect decreases in all three businesses. - Segment adjusted EBIT was down
68% , mainly due to lower volume partially offset by lower manufacturing and logistics costs.
International (Sales Outside the
- Net sales decreased
5% , with 22 points of favorable price mix more than offset by 14 points of unfavorable foreign exchange rates and 13 points of lower volume. Organic sales grew9% . - Segment adjusted EBIT increased
48% behind the benefit of pricing, which more than offset unfavorable foreign exchange rates and the impact of lower volume.
Fiscal Year 2024 Outlook
The company is updating the following elements of its fiscal year 2024 outlook:
- Net sales are now expected to be down mid- to high single digits, updated to reflect the impact from the cyberattack. This compares to the previous expectation of sales that are flat to up
2% . This continues to reflect about 2 points of unfavorable impact from foreign exchange rates. - Gross margin is now expected to be about flat, reflecting the combined benefit of pricing actions, cost savings and supply chain optimization offset by input cost inflation and the impact from the cyberattack. This compares to the previous expectation of an increase between 150 and 175 basis points.
- Selling and administrative expenses are now expected to be about
16% of net sales, including about 2 points of impact related to investments to enhance the company's digital capabilities, implementation of the streamlined operating model and expenses resulting from the cyberattack. This compares to the previous expectation of between15% and16% of net sales. - Advertising and sales promotion spending is expected to be about
11% of net sales. This continues to reflect the company's stepped-up efforts to emphasize the superior value of its brands at a time when consumers are increasingly becoming more value focused as well as to support efforts to rebuild market share. - The company's effective tax rate is now expected to be between
23% and24% , compared to the previous expectation of about24% . - Net of these factors, fiscal year diluted EPS is now expected to be between
and$2.10 , or an increase of$2.60 75% to117% , respectively. This compares to previous expectations between and$4.65 , or an increase of$4.95 290% to316% , respectively. Adjusted EPS is now expected to be between and$4.30 , or a decrease of$4.80 16% to6% . This compares to previous expectations of between and$5.60 , or an increase of$5.90 10% to16% , respectively. Adjusted EPS excludes the long-term strategic investments in digital capabilities and productivity enhancements, which continue to be estimated at about70 cents ; a25-cent charge related to the streamlined operating model; and incremental charges resulting from the cyberattack of about25 cents . It also excludes a noncash charge of about related to termination of the company's domestic qualified pension plan.$1.00
1 | Organic sales growth / (decrease) and adjusted EPS are non-GAAP measures. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures. | ||||
2 | Adjusted EBIT is a non-GAAP measure. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures. |
Clorox Earnings Conference Call Schedule
At approximately 4:15 p.m. ET today, Clorox will post prepared management remarks regarding its first-quarter fiscal year 2024 results.
At 5 p.m. ET today, the company will host a live Q&A audio webcast with CEO Linda Rendle and Chief Financial Officer Kevin Jacobsen to discuss the results.
Links to the live (and archived) webcast, press release and prepared remarks can be found at Clorox Quarterly Results.
For More Detailed Financial Information
Visit the company's Quarterly Results for the following:
- Supplemental unaudited volume and sales growth information
- Supplemental unaudited gross margin drivers information
- Supplemental unaudited cash flow information and free cash flow reconciliation
- Supplemental unaudited reconciliation of earnings (losses) before interest and taxes (EBIT) and adjusted EBIT
- Supplemental unaudited reconciliation of adjusted earnings per share (EPS)
Note: Percentage and basis-point, or point, changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate.
About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands, which include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Natural Vitality®, can be found in about nine of 10 U.S. homes and internationally with brands such as Ayudin®, Clorinda®, Chux® and Poett®. Headquartered in
CLX-F
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements regarding the expected or potential impact of the company's operational disruption stemming from a cyberattack, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2023, and in the company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, and as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: unfavorable general economic and geopolitical conditions beyond our control, including supply chain disruptions, labor shortages, wage pressures, rising inflation, the interest rate environment, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including ongoing conflicts in the
The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
Non-GAAP Financial Information
- This press release contains non-GAAP financial information related to organic sales growth / (decrease), adjusted EPS and segment adjusted EBIT for the first quarter of fiscal year 2024, as well as adjusted EPS outlook for fiscal year 2024.
- Clorox defines organic sales growth / (decrease) as GAAP net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.
- Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to continue to operate throughout the relevant periods, and the company's estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth / (decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.
- Adjusted EPS is defined as diluted earnings per share that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
- Adjusted EPS is supplemental information that management uses to help evaluate the company's historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as incremental costs related to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions, and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company's underlying operating performance on a consistent basis over time. However, adjusted EPS may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.
- Adjusted EBIT represents earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as incremental costs related to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability during the period. The company uses this measure to assess the operating results and performance of its segments, perform analytical comparisons, identify strategies to improve performance, and allocate resources to each segment. Management believes that the presentation of adjusted EBIT excluding these items is useful to investors to assess operating performance on a consistent basis by removing the impact of the items that management believes do not directly reflect the performance of each segment's underlying operations. However, adjusted EBIT may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.
- The reconciliation tables below refer to the equivalent GAAP measures adjusted as applicable for the following items:
Pension Settlement
In the second quarter of fiscal year 2024, a one-time, noncash settlement charge is expected to be recognized related to the previously disclosed termination of the domestic qualified pension plan, as plan obligations are settled through both lump sum payouts and annuity purchases. The actual amount of the settlement charge could vary based on the final valuation of assets and liabilities.
Cyberattack Costs
As previously disclosed, incremental costs were incurred by the company as the result of a cyberattack. These costs relate primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs from the resulting disruption to the company's business operations.
The company has not recognized any insurance proceeds in the three months ended Sept. 30, 2023, related to the cyberattack. The timing of recognizing insurance recoveries may differ from the timing of recognizing the associated expenses. Costs associated with ongoing cybersecurity monitoring and prevention as well as enhancement to the company's cybersecurity program are not included within this adjustment. The company expects to continue to incur costs associated with the cyberattack in future periods.
Due to the nature, scope and magnitude of these costs, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.
Streamlined Operating Model
In the first quarter of fiscal year 2023, Clorox began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the company's ability to respond more quickly to changing consumer behaviors and innovate faster. The company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.
Once fully implemented, the company expects annual cost savings of approximately
Digital Capabilities and Productivity Enhancements Investment
As announced in August 2021, the company plans to invest approximately
Of the total
Due to the nature, scope and magnitude of this investment, these costs are considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, will cease at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.
The following table provides reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease), the most comparable GAAP measure:
Three months ended Sept. 30, 2023 | |||||||||
Percentage change versus the year-ago period | |||||||||
Health and Wellness | Household | Lifestyle | International | Total Company (1) | |||||
Net sales growth / (decrease) (GAAP) | (23) % | (23) % | (28) % | (5) % | (20) % | ||||
Add: Foreign exchange | — | — | — | 14 | 2 | ||||
Add/(Subtract): Divestitures/acquisitions | — | — | — | — | — | ||||
Organic sales growth / (decrease) (non-GAAP) | (23) % | (23) % | (28) % | 9 % | (18) % | ||||
(1) | Total Company includes Corporate and Other. |
The following tables provide reconciliations of adjusted diluted earnings per share (non-GAAP) to diluted earnings per share, the most comparable GAAP measure:
Adjusted Diluted Earnings Per Share (EPS) | |||||||||
(Dollars in millions except per share data) | |||||||||
Diluted earnings per share | |||||||||
Three months ended | |||||||||
9/30/2023 | 9/30/2022 | % Change | |||||||
As reported (GAAP) | $ 0.17 | $ 0.68 | (75) % | ||||||
Cyberattack costs (1) | 0.15 | — | |||||||
Streamlined operating model (2) | — | 0.12 | |||||||
Digital capabilities and productivity enhancements investment (3) | 0.17 | 0.13 | |||||||
As adjusted (Non-GAAP) | $ 0.49 | $ 0.93 | (47) % | ||||||
(1) During the three months ended Sept. 30, 2023, the company incurred approximately | |||||||||
(2) During the three months ended Sept. 30, 2023, and 2022, the company incurred | |||||||||
(3) During the three months ended Sept. 30, 2023, and 2022, the company incurred approximately | |||||||||
Three months ended | |||||||||
9/30/2023 | 9/30/2022 | ||||||||
External consulting fees (a) | $ 21 | $ 16 | |||||||
IT project personnel costs (b) | 2 | 1 | |||||||
Other (c) | 4 | 3 | |||||||
Total | $ 27 | $ 20 | |||||||
(a) Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation. | |||||||||
(b) Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | |||||||||
(c) Comprised of various other expenses associated with the company's new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses. | |||||||||
Full year 2024 outlook | |||||||||
Diluted earnings per share | |||||||||
Low | High | ||||||||
As estimated (GAAP) | $ 2.10 | $ 2.60 | |||||||
Pension settlement (4) | 1.00 | 1.00 | |||||||
Cyberattack costs (5) | 0.25 | 0.25 | |||||||
Streamlined operating model (6) | 0.25 | 0.25 | |||||||
Digital capabilities and productivity enhancements investment (7) | 0.70 | 0.70 | |||||||
As adjusted (Non-GAAP) | $ 4.30 | $ 4.80 | |||||||
(4) In FY24, the company expects to incur approximately | |||||||||
(5) In FY24, the company expects to incur approximately | |||||||||
(6) In FY24, the company expects to incur approximately | |||||||||
(7) In FY24, the company expects to incur approximately |
The following table provides reconciliation of adjusted EBIT (non-GAAP) to earnings (losses) before income taxes, the most comparable GAAP measure:
Reconciliation of earnings | |||
Three months ended | |||
9/30/2023 | 9/30/2022 | ||
Earnings (losses) before income taxes | $ 29 | $ 116 | |
Interest income | (10) | (2) | |
Interest expense | 21 | 22 | |
Cyberattack costs | 24 | — | |
Streamlined operating model | — | 19 | |
Digital capabilities and productivity enhancements investment | 27 | 20 | |
Adjusted EBIT | $ 91 | $ 175 | |
Condensed Consolidated Statements of Earnings (Unaudited) | |||||
Dollars in millions, except per share data | |||||
Three months ended | |||||
09/30/2023 | 09/30/2022 | ||||
Net sales | $ 1,386 | $ 1,740 | |||
Cost of products sold | 854 | 1,114 | |||
Gross profit | 532 | 626 | |||
Selling and administrative expenses | 276 | 261 | |||
Advertising costs | 165 | 161 | |||
Research and development costs | 29 | 32 | |||
Interest expense | 21 | 22 | |||
Other (income) expense, net | 12 | 34 | |||
Earnings before income taxes | 29 | 116 | |||
Income tax expense | 4 | 29 | |||
Net earnings | 25 | 87 | |||
Less: Net earnings attributable to noncontrolling interests | 3 | 2 | |||
Net earnings attributable to Clorox | $ 22 | $ 85 | |||
Net earnings per share attributable to Clorox | |||||
Basic net earnings per share | $ 0.17 | $ 0.69 | |||
Diluted net earnings per share | $ 0.17 | $ 0.68 | |||
Weighted average shares outstanding (in thousands) | |||||
Basic | 123,973 | 123,339 | |||
Diluted | 124,650 | 123,914 |
Reportable Segment Information | |||||
(Unaudited) | |||||
Dollars in millions | |||||
Net sales | |||||
Three months ended | |||||
9/30/2023 | 9/30/2022 | % Change(1) | |||
Health and Wellness | $ 504 | $ 657 | (23) % | ||
Household | 325 | 423 | (23) | ||
Lifestyle | 229 | 320 | (28) | ||
International | 270 | 285 | (5) | ||
Corporate and Other (2) | 58 | 55 | 5 | ||
Total | $ 1,386 | $ 1,740 | (20) % | ||
Segment adjusted EBIT | |||||
Three months ended | |||||
9/30/2023 | 9/30/2022 | % Change(1) | |||
Health and Wellness | $ 104 | 133 | (22) % | ||
Household | (4) | 22 | (118) | ||
Lifestyle | 19 | 60 | (68) | ||
International | 34 | 23 | 48 | ||
Corporate and Other | (62) | (63) | (2) | ||
Total | $ 91 | $ 175 | (48) % | ||
Interest income | 10 | 2 | |||
Interest expense | (21) | (22) | |||
Cyberattack costs (3) | (24) | — | |||
Streamlined operating model (4) | — | (19) | |||
Digital capabilities and productivity enhancements investment (5) | (27) | (20) | |||
Earnings before income taxes | $ 29 | $ 116 | (75) % | ||
(1) Percentages based on rounded numbers. | |||||
(2) Corporate and Other includes the Vitamin, Minerals and Supplements business. | |||||
(3) Represents costs related to the cyberattack of | |||||
(4) Represents restructuring and related costs, net for implementation of the streamlined operating model of | |||||
(5) Represents expenses related to the company's digital capabilities and productivity enhancements investment of |
Condensed Consolidated Balance Sheets | |||||||||||
Dollars in millions | |||||||||||
9/30/2023 | 6/30/2023 | 9/30/2022 | |||||||||
(Unaudited) | (Unaudited) | ||||||||||
ASSETS | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 518 | $ | 367 | $ | 278 | |||||
Receivables, net | 581 | 688 | 612 | ||||||||
Inventories, net | 710 | 696 | 755 | ||||||||
Prepaid expenses and other current assets | 102 | 77 | 118 | ||||||||
Total current assets | 1,911 | 1,828 | 1,763 | ||||||||
Property, plant and equipment, net | 1,317 | 1,345 | 1,322 | ||||||||
Operating lease right-of-use assets | 328 | 346 | 336 | ||||||||
Goodwill | 1,246 | 1,252 | 1,546 | ||||||||
Trademarks, net | 541 | 543 | 685 | ||||||||
Other intangible assets, net | 162 | 169 | 190 | ||||||||
Other assets | 486 | 462 | 311 | ||||||||
Total assets | $ | 5,991 | $ | 5,945 | $ | 6,153 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities | |||||||||||
Notes and loans payable | $ | 347 | $ | 50 | $ | 348 | |||||
Current operating lease liabilities | 88 | 87 | 78 | ||||||||
Accounts payable and accrued liabilities | 1,678 | 1,659 | 1,584 | ||||||||
Income Taxes Payable | 115 | 121 | — | ||||||||
Total current liabilities | 2,228 | 1,917 | 2,010 | ||||||||
Long-term debt | 2,478 | 2,477 | 2,475 | ||||||||
Long-term operating lease liabilities | 290 | 310 | 308 | ||||||||
Other liabilities | 837 | 825 | 805 | ||||||||
Deferred income taxes | 27 | 28 | 59 | ||||||||
Total liabilities | 5,860 | 5,557 | 5,657 | ||||||||
Commitments and contingencies | |||||||||||
Stockholders' equity | |||||||||||
Preferred stock | — | — | — | ||||||||
Common stock | 131 | 131 | 131 | ||||||||
Additional paid-in capital | 1,246 | 1,245 | 1,193 | ||||||||
Retained earnings | 299 | 583 | 832 | ||||||||
Treasury stock | (1,219) | (1,246) | (1,315) | ||||||||
Accumulated other comprehensive net (loss) income | (494) | (493) | (515) | ||||||||
Total Clorox stockholders' (deficit) equity | (37) | 220 | 326 | ||||||||
Noncontrolling interests | 168 | 168 | 170 | ||||||||
Total stockholders' equity | 131 | 388 | 496 | ||||||||
Total liabilities and stockholders' equity | $ | 5,991 | $ | 5,945 | $ | 6,153 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/clorox-reports-q1-fiscal-year-2024-results-updates-outlook-301974644.html
SOURCE The Clorox Company
FAQ
What were the net sales for The Clorox Company in the first quarter of fiscal year 2024?
What was the decrease in net sales compared to the year-ago quarter?
What was the reason for the decrease in net sales?
What was the gross margin for the first quarter of fiscal year 2024?
What was the decrease in diluted net earnings per share compared to the year-ago quarter?
What was the year-to-date net cash provided by operations?